Altered MiRNA Expression in Gastric Cancer: a Systematic Review and Meta-Analysis

Background/Aims: Aberrant microRNA expression has the potential to be used for early diagnosis of gastric cancer or to predict survival and treatment response. This study performed a systematic review and meta-analysis of altered miRNAs in gastric cancer in order to assess the use of miRNAs as novel...

Full description

Bibliographic Details
Main Authors: Qi-Xian Wang, You-Qing Zhu, Hu Zhang, Jun Xiao
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2015-01-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/369750
_version_ 1819266750927077376
author Qi-Xian Wang
You-Qing Zhu
Hu Zhang
Jun Xiao
author_facet Qi-Xian Wang
You-Qing Zhu
Hu Zhang
Jun Xiao
author_sort Qi-Xian Wang
collection DOAJ
description Background/Aims: Aberrant microRNA expression has the potential to be used for early diagnosis of gastric cancer or to predict survival and treatment response. This study performed a systematic review and meta-analysis of altered miRNAs in gastric cancer in order to assess the use of miRNAs as novel biomarkers for early detection and prognosis prediction of gastric cancer. Methods: We retrieved published articles from the PubMed online database and obtained different sets of data on miRNAs expression profiling in gastric cancer and highlighted the most frequently dysregulated miRNAs in gastric cancer. We then extracted studies that used quantitative RT-PCR and then pooled them together by using meta-disc software (version 1.4). Results: We found that there were 47 aberrantly expressed miRNAs in gastric cancer (29 up-regulated and 18 down-regulated) that were most frequently reported in the literature. In publications that provided information on specific miRNA expression vs. diagnostic value, the pooled data showed good sensitivity and specificity as well as high levels of overall accuracy. However, specimen types could be a factor that introduces substantial heterogeneity. Published studies also showed association of altered miRNA expression with clinicopathological data from gastric cancer patients. Conclusion: Thus, various miRNAs are differentially expressed in gastric cancer and some of them could be further evaluated as biomarkers for early diagnosis of gastric cancer and prediction of prognosis or treatment response.
first_indexed 2024-12-23T21:06:15Z
format Article
id doaj.art-d075d4dbfe8e449ea9f4563c95fd4670
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-12-23T21:06:15Z
publishDate 2015-01-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-d075d4dbfe8e449ea9f4563c95fd46702022-12-21T17:31:12ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782015-01-0135393394410.1159/000369750369750Altered MiRNA Expression in Gastric Cancer: a Systematic Review and Meta-AnalysisQi-Xian WangYou-Qing ZhuHu ZhangJun XiaoBackground/Aims: Aberrant microRNA expression has the potential to be used for early diagnosis of gastric cancer or to predict survival and treatment response. This study performed a systematic review and meta-analysis of altered miRNAs in gastric cancer in order to assess the use of miRNAs as novel biomarkers for early detection and prognosis prediction of gastric cancer. Methods: We retrieved published articles from the PubMed online database and obtained different sets of data on miRNAs expression profiling in gastric cancer and highlighted the most frequently dysregulated miRNAs in gastric cancer. We then extracted studies that used quantitative RT-PCR and then pooled them together by using meta-disc software (version 1.4). Results: We found that there were 47 aberrantly expressed miRNAs in gastric cancer (29 up-regulated and 18 down-regulated) that were most frequently reported in the literature. In publications that provided information on specific miRNA expression vs. diagnostic value, the pooled data showed good sensitivity and specificity as well as high levels of overall accuracy. However, specimen types could be a factor that introduces substantial heterogeneity. Published studies also showed association of altered miRNA expression with clinicopathological data from gastric cancer patients. Conclusion: Thus, various miRNAs are differentially expressed in gastric cancer and some of them could be further evaluated as biomarkers for early diagnosis of gastric cancer and prediction of prognosis or treatment response.http://www.karger.com/Article/FullText/369750DiagnosisGastric cancerMiRNAMicroarrayBiomarker
spellingShingle Qi-Xian Wang
You-Qing Zhu
Hu Zhang
Jun Xiao
Altered MiRNA Expression in Gastric Cancer: a Systematic Review and Meta-Analysis
Cellular Physiology and Biochemistry
Diagnosis
Gastric cancer
MiRNA
Microarray
Biomarker
title Altered MiRNA Expression in Gastric Cancer: a Systematic Review and Meta-Analysis
title_full Altered MiRNA Expression in Gastric Cancer: a Systematic Review and Meta-Analysis
title_fullStr Altered MiRNA Expression in Gastric Cancer: a Systematic Review and Meta-Analysis
title_full_unstemmed Altered MiRNA Expression in Gastric Cancer: a Systematic Review and Meta-Analysis
title_short Altered MiRNA Expression in Gastric Cancer: a Systematic Review and Meta-Analysis
title_sort altered mirna expression in gastric cancer a systematic review and meta analysis
topic Diagnosis
Gastric cancer
MiRNA
Microarray
Biomarker
url http://www.karger.com/Article/FullText/369750
work_keys_str_mv AT qixianwang alteredmirnaexpressioningastriccancerasystematicreviewandmetaanalysis
AT youqingzhu alteredmirnaexpressioningastriccancerasystematicreviewandmetaanalysis
AT huzhang alteredmirnaexpressioningastriccancerasystematicreviewandmetaanalysis
AT junxiao alteredmirnaexpressioningastriccancerasystematicreviewandmetaanalysis